Endovia Health Sciences Capital Expenditures (CapEx) Growth & History (EDVA)
Endovia Health Sciences's capital expenditures (capex) was $3,235 for fiscal 2024.
View full Endovia Health Sciences company overviewEndovia Health Sciences annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $3,235 | −$10,878 | −77.08% |
| 2023 | 2023-12-31 | $14,113 | −$88,585 | −86.26% |
| 2022 | 2022-12-31 | $102,698 | $102,698 | — |
| 2021 | 2021-12-31 | $0 | −$91,066 | — |
| 2020 | 2020-12-31 | $91,066 | $78,514 | +625.51% |
| 2019 | 2019-12-31 | $12,552 | −$63,081 | −83.40% |
| 2018 | 2018-12-31 | $75,633 | $17,358 | +29.79% |
| 2017 | 2017-12-31 | $58,275 | −$149 | −0.26% |
| 2016 | 2016-12-31 | $58,424 | $31,544 | +117.35% |
| 2015 | 2015-12-31 | $26,880 | −$3,507 | −11.54% |
| 2014 | 2014-12-31 | $30,387 | — | — |
Endovia Health Sciences quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | $3,235 | $3,235 | — |
| Q1 2024 | 2024-03-31 | $0 | −$10,571 | — |
| Q4 2023 | 2023-12-31 | $1,500 | −$55,778 | −97.38% |
| Q3 2023 | 2023-09-30 | $0 | −$45,420 | — |
| Q2 2023 | 2023-06-30 | $2,042 | $2,042 | — |
| Q1 2023 | 2023-03-31 | $10,571 | $10,571 | — |
| Q4 2022 | 2022-12-31 | $57,278 | — | — |
| Q3 2022 | 2022-09-30 | $45,420 | — | — |
| Q2 2022 | 2022-06-30 | $0 | — | — |
| Q1 2022 | 2022-03-31 | $0 | — | — |
| Q4 2020 | 2020-12-31 | $81,373 | $78,763 | +3017.74% |
| Q3 2020 | 2020-09-30 | $4,254 | −$1,162 | −21.45% |
| Q2 2020 | 2020-06-30 | $3,020 | $182 | +6.41% |
| Q1 2020 | 2020-03-31 | $2,419 | −$4,945 | −67.15% |
| Q4 2019 | 2019-12-31 | $2,610 | −$28,134 | −91.51% |
| Q3 2019 | 2019-09-30 | $5,416 | −$14,115 | −72.27% |
| Q2 2019 | 2019-06-30 | $2,838 | −$9,768 | −77.49% |
| Q1 2019 | 2019-03-31 | $7,364 | −$5,388 | −42.25% |
| Q4 2018 | 2018-12-31 | $30,744 | $20,668 | +205.12% |
| Q3 2018 | 2018-09-30 | $19,531 | $9,398 | +92.75% |
| Q2 2018 | 2018-06-30 | $12,606 | −$9,081 | −41.87% |
| Q1 2018 | 2018-03-31 | $12,752 | −$3,627 | −22.14% |
| Q4 2017 | 2017-12-31 | $10,076 | −$5,154 | −33.84% |
| Q3 2017 | 2017-09-30 | $10,133 | −$5,593 | −35.57% |
| Q2 2017 | 2017-06-30 | $21,687 | $13,917 | +179.11% |
| Q1 2017 | 2017-03-31 | $16,379 | −$3,319 | −16.85% |
| Q4 2016 | 2016-12-31 | $15,230 | −$1,686 | −9.97% |
| Q3 2016 | 2016-09-30 | $15,726 | $11,037 | +235.38% |
| Q2 2016 | 2016-06-30 | $7,770 | $4,504 | +137.91% |
| Q1 2016 | 2016-03-31 | $19,698 | $17,689 | +880.49% |
| Q4 2015 | 2015-12-31 | $16,916 | — | — |
| Q3 2015 | 2015-09-30 | $4,689 | — | — |
| Q2 2015 | 2015-06-30 | $3,266 | — | — |
| Q1 2015 | 2015-03-31 | $2,009 | — | — |
Endovia Health Sciences capital expenditures (capex) trends
Over the last five fiscal years, Endovia Health Sciences's capital expenditures (capex) decreased from $12,552 to $3,235, a change of −$9,317. The latest reported quarter, Q3 2024, shows $3,235.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Endovia Health Sciences source filings ↗